Overcoming barriers to the adoption and implementation of predictive modeling and machine learning in clinical care: what can we learn from US academic medical centers?

被引:49
|
作者
Watson, Joshua [1 ]
Hutyra, Carolyn A. [2 ]
Clancy, Shayna M. [3 ]
Chandiramani, Anisha [4 ,5 ]
Bedoya, Armando [5 ,6 ]
Ilangovan, Kumar [4 ,5 ]
Nderitu, Nancy [7 ]
Poon, Eric G. [4 ,5 ]
机构
[1] Duke Univ, Dept Surg, Sch Med, Durham, NC 27705 USA
[2] Duke Univ, Dept Orthoped Surg, Sch Med, Durham, NC 27705 USA
[3] Duke Univ, Duke Canc Inst, Sch Med, Durham, NC 27705 USA
[4] Duke Univ, Dept Med, Div Gen Internal Med, Sch Med, Durham, NC 27705 USA
[5] Duke Univ Hlth Syst, Duke Hlth Technol Solut, Durham, NC USA
[6] Duke Univ, Dept Med, Div Pulm Allergy & Crit Care Med, Sch Med, Durham, NC 27705 USA
[7] Duke Univ, Dept Biostat & Bioinformat, Sch Med, Durham, NC 27705 USA
关键词
machine learning; artificial intelligence; qualitative evaluation; predictive models; ELECTRONIC HEALTH RECORDS; ARTIFICIAL-INTELLIGENCE; SYSTEM;
D O I
10.1093/jamiaopen/ooz046
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
There is little known about how academic medical centers (AMCs) in the US develop, implement, and maintain predictive modeling and machine learning (PM and ML) models. We conducted semi-structured interviews with leaders from AMCs to assess their use of PM and ML in clinical care, understand associated challenges, and determine recommended best practices. Each transcribed interview was iteratively coded and reconciled by a minimum of 2 investigators to identify key barriers to and facilitators of PM and ML adoption and implementation in clinical care. Interviews were conducted with 33 individuals from 19 AMCs nationally. AMCs varied greatly in the use of PM and ML within clinical care, from some just beginning to explore their utility to others with multiple models integrated into clinical care. Informants identified 5 key barriers to the adoption and implementation of PM and ML in clinical care: (1) culture and personnel, (2) clinical utility of the PM and ML tool, (3) financing, (4) technology, and (5) data. Recommendation to the informatics community to overcome these barriers included: (1) development of robust evaluation methodologies, (2) partnership with vendors, and (3) development and dissemination of best practices. For institutions developing clinical PM and ML applications, they are advised to: (1) develop appropriate governance, (2) strengthen data access, integrity, and provenance, and (3) adhere to the 5 rights of clinical decision support. This article highlights key challenges of implementing PM and ML in clinical care at AMCs and suggests best practices for development, implementation, and maintenance at these institutions.
引用
收藏
页码:167 / 172
页数:6
相关论文
共 41 条
  • [31] What can we learn from the online learning experiences of medical students in Poland during the SARS-CoV-2 pandemic?
    Pokryszko-Dragan, Anna
    Marschollek, Karol
    Nowakowska-Kotas, Marta
    Aitken, Gillian
    [J]. BMC MEDICAL EDUCATION, 2021, 21 (01)
  • [32] What can we learn from the online learning experiences of medical students in Poland during the SARS-CoV-2 pandemic?
    Anna Pokryszko-Dragan
    Karol Marschollek
    Marta Nowakowska-Kotas
    Gillian Aitken
    [J]. BMC Medical Education, 21
  • [33] What can we learn from problem-based learning tutors at a graduate entry medical school? A mixed method approach
    Doherty, Diane O.
    Mc Keague, Helena
    Harney, Sarah
    Browne, Gerard
    McGrath, Deirdre
    [J]. BMC MEDICAL EDUCATION, 2018, 18
  • [34] What can we learn from problem-based learning tutors at a graduate entry medical school? A mixed method approach
    Diane O Doherty
    Helena Mc Keague
    Sarah Harney
    Gerard Browne
    Deirdre McGrath
    [J]. BMC Medical Education, 18
  • [35] Chronic Pain, Medical Students, and Primary Care Commentary on "What Can We Learn From First-Year Medical Students' Perception of Pain in the Primary Care Setting"
    Norris, Tom E.
    [J]. PAIN MEDICINE, 2011, 12 (08) : 1137 - 1138
  • [36] Learning and Mislearning across Borders: What Can We (Not) Learn from the 2006 Health Care Reform in the Netherlands? Commentary on Rosenau and Lako
    Okma, Kieke G. H.
    [J]. JOURNAL OF HEALTH POLITICS POLICY AND LAW, 2008, 33 (06) : 1057 - 1071
  • [37] What we can learn from the INSPIRE study about improving prevention and clinical care for injection drug users living with HIV
    Jones, T. Stephen
    Vlahov, David
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 : S31 - S34
  • [38] Methicillin-resistant Staphylococcus aureus spreading through medical devices used in nursing care: what can we learn from Portugal?
    Costa, P.
    Graveto, J.
    Santos, C.
    Fernandes, E.
    Albano, H.
    Osorio, N.
    Alarico, S.
    Oliveira, V.
    Ferreira, S.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 292 - 293
  • [39] Comment on Haase et al. Addressing burnout in clinical pharmacy: What can we learn from other health care disciplines?
    Pillinger, Kelly E.
    Trawinski, Allison C.
    Melaragno, Jennifer I.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2020, 3 (06): : 1155 - 1156
  • [40] The Author's Respond to Comment on Haase et al. Addressing burnout in clinical pharmacy: What can we learn from other health care disciplines?
    Haase, Krystal K.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2020, 3 (06): : 1157 - 1157